Prevalence of Antibodies to Hepatitis B Core Antigen in Blood Donors in the Middle West Region of Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 2, 2001, Pages 185-187

  Aguiar, José Ivan ^c   Aguiar, Eliana ^c   Paniago, Anamaria ^c   Cunha, Rivaldo ^c   Galvão, Luciney ^a   Daher, Roberto ^b  

^a Ctro Hematol Hemoterapia Mato G   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Antibodies to hepatitis B antigen; Hepatitis B; Hepatitis C

Indexed keywords

HEPATITIS C VIRUS;

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; BRAZIL; HEPATITIS B; HUMAN; IMMUNOLOGY; MIDDLE AGED; PREVALENCE;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BLOOD DONORS; BRAZIL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; MIDDLE AGED; PREVALENCE;

EID: 0035257880     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000200009     Document Type: Article

References (25)

1. Barbara JAJ 1994. Hepatitis B: old virus, new problems? Vox Sang 67: 239-242.
2. Burrel CJ 1980. Serological markers of hepatitis B. Clin Gastroenterol 9: 47-63.
3. Chung HT, Lee JS, Lok AS 1993. Prevention posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology 18: 1045-1049.
4. Dodd RY 1995. Transfusion-transmitted hepatitis virus infection. Hematol/Oncol Clin North Am 9: 137-153.
5. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG 1994. Epi Info, version 6. A word processing database, and statistics program for epidemiology on microcomputers, Center of Diseases Control and Prevention, Atlanta, GA.
6. Douglas DD, Taswell HF, Rekela J, Rabe D 1993. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with low prevalence of hepatitis B serological markers. Transfusion 33: 212-216.
7. Gomes AS, Yoshida CFT, Niel C 1996. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 40: 133-138.
8. Gonçales Júnior FL, Boccato RSB, Pedro RJ, da Silva LJ, Papaiordanou PMO, Souza CA, Gonçales NSL, Pellegrino Júnior J 1993. Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-Campinas. Rev Inst Med Trop São Paulo 35: 45-51.
9. Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA 1984. Epidemiological analysis of the significance of low positive test results on antibody to hepatitis B and core antigens. J Clin Microbiol 19: 521-525.
10. Hemopa-Hemocentro do Estado do Pará 1994. Informative Hemopa no 6.
11. Hughes W, Barr A, Dow BC, Follett EA, Barbara JAJ 1995. A multicenter assessment of the specificity often anti-HBc screening tests. Transfus Med 5: 225-230.
12. Jamelka HIJ, Wicki NA, Grob PJ 1994. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 21: 269-272.
13. Jilg W, Sieger E, Zachoval R, Schätzl H 1995. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 23: 14-20.
14. Luo KX, Zhou R, Chao H, Liang ZS, Jiang S 1991. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 35: 55-59.
15. McMahon DJ, Bender TR, Berquist KR, Schreeder MT, Harpster AP 1981. Delayed development of antibody to hepatitis B surface antigen for symptomatic infection with hepatitis B virus. J Clin Microbiol 14: 130-134.
16. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ 1995. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 35: 5-12.
17. Nandi J, Benerjee K 1992. Detection of hepatitis B virus DNA in donor blood by the polymerase chain reaction. Nat Med J India 5: 5-7.
18. NIH-National Institute of Health 1995. Infectious disease testing for blood transfusion. Consens Statement 13: 1-29.
19. Sánchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, Garcia de Pesqueira F, Prieto J, Lissen E 1993. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 17: 288-293.
20. Scully LJ, Sung H, Pennie R, Gill P 1994. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individual, using the polymerase chain reaction. J Med Virol 44: 293-297.
21. Vanderborght BOM, Reis AMM, Rouzerè C, Yoshida CFT, Franco LGP, Van Heuverswijn H, Moreira Pereira J 1993. Prevalence of anti-Hepatitis C virus in the blood donor population of Rio de Janeiro, Brazil. Vox Sang 65: 122-125.
22. Vasconcelos HCFF, Yoshida CFT, Vanderborght BOM, Schatzmayr HG 1994. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Mem Inst Oswaldo Cruz 89: 503-507.
23. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS 1991. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 163: 397-399.
24. Wendel S, Luzzi JR, Russo C, Fontão RCL, Ghaname J 1991. Pesquisa de anti-HBc em doadores de sangue em São Paulo: deverá esse teste ser adotado pelo Brasil? Rev Paul Med 109: 77-83.
25. Zuckerman AJ 1985. Controversies in immunization against Hepatitis B. Hepatology 5: 1227-1230.